<DOC>
	<DOCNO>NCT01509209</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Cossac L tablet treatment vasomotor rhinitis</brief_summary>
	<brief_title>Efficacy/Safety Pseudoephedrine Plus Levocetirizine Versus Placebo Patients With Vasomotor Rhinitis</brief_title>
	<detailed_description>randomize , double-blind , placebo-controlled , phase 3</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Vasomotor</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>Diagnosis vasomotor rhinitis Significant concomitant medical condition Use corticosteroid allergy medication study Considered investigator appropriate participate clinical study othe reason</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>vasomotor</keyword>
	<keyword>pseudoephedrine</keyword>
	<keyword>levocetirizine</keyword>
</DOC>